USM: Women Leading Innovation & Resilience in Vietnam’s Health Sector

USM workers engaged in the production of stents, catheters, and other medical equipment.
ADI provided an anchor equity investment in 2022 into SWEEF’s Fund I, helping mobilise millions in co-investment from private and public investors. As an equity fund, SWEEF used this capital to invest into USM Healthcare.
USM Healthcare, founded in 2012 by Ms. VÕ XUÂN BỘI LÂM, produces medical products like coronary stent systems. As the sole domestic manufacturer in this sector, USM sold 24 million units in 2023, highlighting its essential role in meeting national healthcare needs. By offering high quality and relatively low-cost stents, USM ensures broader access to lifesaving treatments for low- to medium-income patients. With plans to expand into orthopedics, USM’s provision of inclusive medical products is expected to continue to grow in coming years.
Ms. LÂM, now Chair of the Board of Directors, champions gender equality and diversity. Aligned with the 2X Challenge, USM proudly boasts 50% women in senior management and 57% female representation among its 254 full-time employees. USM’s Code of Conduct and Professional Ethics underscores its dedication to fostering a supportive and ethical work environment.